Adding Hetrombopag to Cyclosporine a Improved Response of Patients with Newly Diagnosed Transfusion-dependent Non-severe Aplastic Anemia
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Marsh J, Ball S, Cavenagh J, Darbyshire P, Dokal I, Gordon-Smith E
. Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol. 2009; 147(1):43-70.
DOI: 10.1111/j.1365-2141.2009.07842.x.
View
2.
Nishio N, Yagasaki H, Takahashi Y, Muramatsu H, Hama A, Yoshida N
. Natural history of transfusion-independent non-severe aplastic anemia in children. Int J Hematol. 2009; 89(4):409-413.
DOI: 10.1007/s12185-009-0302-9.
View
3.
Syed Y
. Hetrombopag: First Approval. Drugs. 2021; 81(13):1581-1585.
DOI: 10.1007/s40265-021-01575-1.
View
4.
Peng G, He G, Chang H, Gao S, Liu X, Chen T
. A multicenter phase II study on the efficacy and safety of hetrombopag in patients with severe aplastic anemia refractory to immunosuppressive therapy. Ther Adv Hematol. 2022; 13:20406207221085197.
PMC: 8972928.
DOI: 10.1177/20406207221085197.
View